Chronic Disease Archives - Page 3 Of 9

ELAHERE (mirvetuximab soravtansine-gynx) injection

ELAHERE (mirvetuximab soravtansine-gynx) injection, for intravenous use Initial U.S. Approval: 2022

Elahere is used to treat ovarian cancer that has high levels of the FRalpha protein. This protein sits on the surface of cells and helps them grow and divide. FRalpha proteins are seen more commonly on certain cancer cells, such as ovarian cancer cells.

Brand Name:	ELAHERE
Generic Name:	mirvetuximab soravtansine-gynx
Strength:	• Injection: 100 mg/20 mL (5 mg/mL) in a single-dose vial.
Manufacturer:	ImmunoGen
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “ELAHERE (mirvetuximab soravtansine-gynx) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for ELAHERE (mirvetuximab soravtansine-gynx) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

empagliflozin and linagliptin tablets

Diabetes

empagliflozin and linagliptin tablets
for oral use Initial U.S. Approval: 2015

Facts about empagliflozin and linagliptin tablets

Approval Date: 2015
Proprietary Name: GLYXAMBI (empagliflozin and linagliptin) tablets
Active Ingredient(s): empagliflozin and linagliptin
FDA-approved use:
Dosage Form: Tablets: • 10 mg empagliflozin/5 mg linagliptin • 25 mg empagliflozin/5 mg linagliptin
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “empagliflozin and linagliptin tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

empagliflozin tablets

Diabetes

empagliflozin tablets,
for oral use Initial U.S. Approval: 2014

As specified in the prescribing information, empagliflozin tablets is indicated for the treatment of type 2 diabetes mellitus. JARDIANCE is indicated: • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, • to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.

Facts about empagliflozin tablets

pproval Date: 2014
Proprietary Name: JARDIANCE (empagliflozin) tablets
Active Ingredient(s): empagliflozin
FDA-approved use: type 2 diabetes mellitus
Dosage Form: Tablets: 10 mg, 25 mg
Medicine Approved By: US FDA
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “empagliflozin tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

ertugliflozin tablets

Diabetes

ertugliflozin tablets
for oral use Initial U.S. Approval: 2017

STEGLATRO is a sodium glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about ertugliflozin tablets

Approval Date: 2017
Proprietary Name: STEGLATRO (ertugliflozin) tablets
Active Ingredient(s): ertugliflozin tablets
Dosage Form: Tablets: 5 mg and 15 mg
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Merck Sharp & Dohme Corp.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ertugliflozin tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

everolimus tablets

Breast Cancer, Gastrointestinal, Kidney, Lung

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis.

Facts about everolimus tablets

Disease Indications-Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer
Manufacturer-Novartis
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA).
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “everolimus tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

exenatide Injection

Diabetes

exenatide Injection
Initial U.S. Approval: 2005

BYETTA is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about exenatide Injection

Approval Date: 2005
Proprietary Name: BYETTA (exenatide) Injection
Active Ingredient(s): exenatide
FDA-approved use: 2 diabetes mellitus.
Dosage Form: BYETTA is supplied as 250 mcg/mL exenatide in: • 5 mcg per dose, 60 doses, 1.2 mL prefilled pen • 10 mcg per dose, 60 doses, 2.4 mL prefilled pen.
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Amylin Pharmaceuticals, Inc.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Full Support:

IPN, Delhi can help with your prescription of the Registered Medical Practitioner (RMP) to get access. Based on your input information received, a step by step guide on how we can help you legally and safely import a medicine “exenatide Injection” will be provided.

Fampridine Tablets

MS

Fampridine 10 mg Modified Release (MR) tablet

Generic Name – Fampyra
Medicine Type – Tablets / Oral
Manufacturer Name – Biogen Idec Ltd
Approval Year – 2011
Approved by – The European Commission

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import fampridine tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

FASENRA (benralizumab) injection

Cardiology

FASENRA (benralizumab) injection

FASENRA is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

Medicine Name: Fasenra
Generic Name: Benralizumab
Dosage Form & Strength: Injection: 30 mg/mL Solution in a Single-dose Prefilled Syringe
Manufactured By: AstraZeneca

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import FASENRA (benralizumab) injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

FOTIVDA (tivozanib) capsules, for oral use

Kidney

FOTIVDA (tivozanib) capsules, for oral use

FOTIVDA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
Source content : www.accessdata.fda.gov

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import FOTIVDA (tivozanib) capsules, for oral use” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Gemcitabine for injection

Ovarian, Breast Cancer, Lung, Pancreatic

gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Gemcitabine hydrochloride is a type of chemotherapy called an antimetabolite. It kills cancer cells and other rapidly growing cells by preventing them from making DNA and RNA.

Facts about Gemcitabine for injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Gemcitabine for injection
Dosage Forms And Strengths: Capsules: • 200 mg/single-use vial • 1 g/single-use vial
Company: Eli Lilly and Company
Current indications: non-small cell lung cancer; NSCLC
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Gemcitabine for injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

List of Oncology Medication For

Chronic Disease

Indian Pharma Network

M: +9891296838 / 9811747774E: med@indianpharmanetwork.co.in

ELAHERE (mirvetuximab soravtansine-gynx) injection, for intravenous use Initial U.S. Approval: 2022

empagliflozin and linagliptin tablets for oral use Initial U.S. Approval: 2015

Access the best support services globally

empagliflozin tablets, for oral use Initial U.S. Approval: 2014

Facts about empagliflozin tablets

Access the best support services globally

ertugliflozin tablets for oral use Initial U.S. Approval: 2017

Facts about ertugliflozin tablets

Access the best support services globally

everolimus tablets for oral suspension Initial U.S. Approval: 2009

Facts about everolimus tablets

Access the best support services globally

exenatide Injection Initial U.S. Approval: 2005

Full Support:

Fampridine 10 mg Modified Release (MR) tablet

Access the best support services globally

FASENRA (benralizumab) injection

Access the best support services globally

FOTIVDA (tivozanib) capsules, for oral use

Access the best support services globally

gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Facts about Gemcitabine for injection

Access the best support services globally

Contact Info

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in

empagliflozin and linagliptin tablets
for oral use Initial U.S. Approval: 2015

empagliflozin tablets,
for oral use Initial U.S. Approval: 2014

ertugliflozin tablets
for oral use Initial U.S. Approval: 2017

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

exenatide Injection
Initial U.S. Approval: 2005